189 related articles for article (PubMed ID: 28838065)
1. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
[TBL] [Abstract][Full Text] [Related]
4. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
5. In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
Xu X; Yang J; Tang Y; Li J; Zhu Y; Lu H; Fei X
Int J Clin Exp Pathol; 2014; 7(10):6705-15. PubMed ID: 25400750
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells.
Wang Y; Fu B; Sun X; Li D; Huang Q; Zhao W; Chen X
Stem Cell Res Ther; 2015 Sep; 6():185. PubMed ID: 26415502
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia Cells.
Jaimes Y; Naaldijk Y; Wenk K; Leovsky C; Emmrich F
Stem Cells; 2017 Mar; 35(3):812-823. PubMed ID: 27862694
[TBL] [Abstract][Full Text] [Related]
9. Effect of human bone marrow mesenchymal stem cell-derived microvesicles on the apoptosis of the multiple myeloma cell line U266.
Vafaeizadeh M; Abroun S; Soufi Zomorrod M
J Cancer Res Clin Oncol; 2024 Jun; 150(6):299. PubMed ID: 38850382
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
[TBL] [Abstract][Full Text] [Related]
11. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
[TBL] [Abstract][Full Text] [Related]
12. Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism.
Liu J; Kuwabara A; Kamio Y; Hu S; Park J; Hashimoto T; Lee JW
Stem Cells; 2016 Dec; 34(12):2943-2955. PubMed ID: 27350036
[TBL] [Abstract][Full Text] [Related]
13. Serum deprivation elevates the levels of microvesicles with different size distributions and selectively enriched proteins in human myeloma cells in vitro.
Sun L; Wang HX; Zhu XJ; Wu PH; Chen WQ; Zou P; Li QB; Chen ZC
Acta Pharmacol Sin; 2014 Mar; 35(3):381-93. PubMed ID: 24374813
[TBL] [Abstract][Full Text] [Related]
14. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
Wang Y; Lu X; He J; Zhao W
Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
[TBL] [Abstract][Full Text] [Related]
15. [Biological properties of mesenchymal stem cells derived from bone marrow of patients with multiple myeloma].
Zhu BD; Ren J; Wang XY; Li X; Nie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1138-42. PubMed ID: 17204180
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
[TBL] [Abstract][Full Text] [Related]
18. Tumor Cell-Derived Microvesicles Induced Not Epithelial-Mesenchymal Transition but Apoptosis in Human Proximal Tubular (HK-2) Cells: Implications for Renal Impairment in Multiple Myeloma.
Zhao A; Kong F; Liu CJ; Yan G; Gao F; Guo H; Guo AY; Chen Z; Li Q
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264449
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
[TBL] [Abstract][Full Text] [Related]
20. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]